Combination of Anti-PD-1 Antibody and Chemotherapy in Metastatic Pancreatic Cancer

Clinical trial NCT03977272 · COMPLETED

Trial details

NCT number: NCT03977272
Sponsor: Zhejiang University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2019-03-27
Primary completion: 2022-07-01
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.